Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran ; volume:5 ; number:1 ; day:22 ; month:4 ; year:2004 ; pages:1-7 ; date:12.2004
Trials ; 5, Heft 1 (22.4.2004), 1-7, 12.2004
- Urheber
-
Boos, Christopher J.
- Beteiligte Personen und Organisationen
-
More, Ranjit S.
SpringerLink (Online service)
- DOI
-
10.1186/1468-6708-5-3
- URN
-
urn:nbn:de:1111-2016050215442
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boos, Christopher J.
- More, Ranjit S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation